Back to results

ResearchSpace@Auckland

Device Therapy In Heart Failure Population In New Zealand

Abstract

dc:description.abstract

Heart failure (HF) is a major burden in developed and developing countries. It is known that HF patients are at risk of sudden cardiac death (SCD). The research presented within this thesis aims to add to the current knowledge in understanding the use of implantable cardioverterdefibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in HF patients in New Zealand and to improve the awareness of these evidence-based device-therapy in the contemporary management of HF patients. Chapter 1 comprises a literature overview on providing background on SCD in HF patients and the role of ICDs in preventing SCD in HF management. Chapter 2 contains a literature review on CRT use in the management of selected HF patients. Chapter 3 describes a study that examines the use of cardiac resynchronisation therapypacemaker (CRT-P) versus cardiac resynchronisation therapy-defibrillator (CRT-D) in patients with impaired left ventricular ejection fraction (LVEF). Chapter 4 describes a study that evaluates the role of a simple risk score to identify HF patients who should have CRT-D versus those who should be treated with a CRT-P even when fulfilling ICD implantation criteria. Chapter 5 reports two observational studies describing the trends and utilisations as well as the outcomes of HF patients with ICD/CRT-D and CRT-P in the Northern Region of New Zealand. A third study reported the gender differences in the use of these devices in New Zealand. An overview of quality of life (QoL) of HF patients has been presented in Chapter 6 followed by a study that describe the burden of hospitalisations, using the novel concept of "Days alive and out of hospital" (DAOH) in HF patients implanted with CRT devices in the Northern Region of New Zealand. The final study in Chapter 6 describes the outcomes of HF patients with primary prevention ICD/CRT-D who underwent unit generator replacement due to battery depletion. Chapter 7 summarises the results of the studies and discusses the wider context and clinical relevance of the findings, as well as making some future research recommendations.

Degree

thesis:*
Name thesis:degree_name
PhD
Level thesis:degree_level
Doctoral
Discipline thesis:degree_discipline
Medicine
Grantor dc:publisher
ResearchSpace@Auckland
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Looi, Khang Li
Advisors dc:contributor.advisor
  • Doughty, R
  • Lever, N

Rights

dc:rights
Statement dc:rights
  • Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2292/49279
OAI identifier oai:identifier
oai:researchspace.auckland.ac.nz:2292/49279

Chain of custody

source
Harvested from
University of Auckland
Base URL
researchspace.auckland.ac.nz/server/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Looi, Khang Li. Device Therapy In Heart Failure Population In New Zealand. Doctoral thesis, ResearchSpace@Auckland, 2019. https://hdl.handle.net/2292/49279